SHR902275
SHR902275 is a potent, selective, and orally active RAF inhibitor targeting RAS mutant cancers. SHR902275 has IC50s of 1.6 nM, 10 nM, and 5.7 nM for cRAF, bRAFwt, and bRAFV600E, respectively. SHR902275 shows cell growth inhibition with GI50s of 1.5 and 0.17 nM, 0.4 nM and 0.32 nM for H358, A375, Calu6, and SK-MEL2 cells respectively[1].
Product Specifications
CAS Number
2695506-82-0
UNSPSC
12352005
Target
Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/shr902275.html
Purity
99.80
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=NN=CC(C(F)(F)F)=C1)NC2=CC=C(C)C(C3=CC4=C(NC(CC5(CCOCC5)O4)=O)C=C3)=C2
Molecular Formula
C26H23F3N4O4
Molecular Weight
512.48
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
B-Raf; C-Raf
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SQLE (ERG1, Squalene Monooxygenase, Squalene Epoxidase, FLJ30795, SE) (MaxLight 550)
Nectin-4 Protein, Cynomolgus, Recombinant (aa 32-349, hFc)
Nectin-4 Protein, Cynomolgus, Recombinant (aa 32-349, hFc)
Nectin-4 Protein, Cynomolgus, Recombinant (aa 32-349, hFc)